DEF: TETE Seeks 3-Month Extension for Business Combination

Technology & Telecommunication Acquisition Corporation (TETE) is seeking shareholder approval to extend its business combination deadline by three months to November 20, 2025, to finalize its merger with Bradbury Capital Holdings Inc.

Summary

• TETE, a Special Purpose Acquisition Company (SPAC), is holding an Extraordinary General Meeting on August 20, 2025, to vote on proposals to extend its business combination deadline.
• The company seeks to amend its Articles of Association and Trust Agreement to extend the Combination Period by three months, from August 20, 2025, to November 20, 2025.
• The primary purpose of the extension is to allow more time to complete the proposed business combination with Bradbury Capital Holdings Inc., for which a definitive agreement was signed on August 2, 2023.
• This is the latest in a series of extensions, with previous approvals in January 2023, July 2023, June 2024, January 2025, and April 2025.
• Prior extensions have resulted in significant shareholder redemptions: 8,373,932 shares in January 2023 ($86,353,662), 149,359 shares in July 2023 ($1,626,736.79), 408,469 shares in June 2024 ($4,872,513.12), 1,993,697 shares in January 2025 ($24,739,495.83), and 3,561 shares in April 2025 ($45,060.56).
• Following the April 2025 redemptions, 570,982 Public Shares remained outstanding.
• As of May 31, 2025, the Trust Account held approximately $7,258,933, and the redemption price per Public Share was approximately $12.71.
• The closing price of Public Shares on the OTC Pink Market on May 30, 2025, was $12.00, indicating that exercising redemption rights would yield approximately $0.71 less per share than selling in the open market at that time.
• The Sponsor has loaned the company an aggregate of $2,817,736 for extension payments as of May 31, 2025, which are convertible into 281,773 TETE Units at $10.00 per unit upon business combination consummation.

Sentiment

Score: 3

Explanation: The filing indicates ongoing struggles to complete a business combination, evidenced by repeated extensions, high redemptions, and a delisting. While a definitive merger agreement exists and the board is committed, the persistent delays and dwindling public share count suggest significant operational and market challenges.

Positives

• The Board of Directors unanimously recommends voting FOR the extension proposals, indicating their commitment to completing the business combination.
• A definitive agreement for a business combination with Bradbury Capital Holdings Inc. is already in place.
• The Sponsor has demonstrated continued financial support by providing $2,817,736 in non-interest-bearing loans for previous extensions.
• Non-redemption agreements were secured with institutional investors in January and April 2025 to help maintain the public share count.

Negatives

• The company has repeatedly required extensions to its business combination deadline, suggesting persistent difficulties in closing a deal.
• Previous extension votes have resulted in substantial shareholder redemptions, significantly depleting the trust account and reducing the number of public shares outstanding.
• The company's securities were delisted from Nasdaq and now trade on the OTC Pink Market, which typically results in reduced liquidity and market visibility.
• The redemption price of approximately $12.71 per share (as of May 31, 2025) is higher than the market closing price of $12.00 (as of May 30, 2025), incentivizing further redemptions and potentially further depleting the trust account.
• There is a significant risk of liquidation if the extension is not approved or if the business combination is not completed by the extended deadline, which would render warrants worthless and result in the Sponsor's initial investment becoming worthless.

Risks

• Inability to complete a Business Combination, including obtaining necessary shareholder approval.
• Volatility of the market price and liquidity of the Ordinary Shares and other securities of the company.
• The use of funds not held in the Trust Account or available from interest income on the Trust Account balance.
• Risk of being deemed an unregistered investment company under the Investment Company Act of 1940, which could force liquidation.
• Potential U.S. foreign investment regulations and review by entities like CFIUS due to the Malaysian citizenship of the Sponsor's controlling individual, which could block or delay a U.S. target acquisition.
• The delisting from Nasdaq to the OTC Pink Market could lead to limited market quotations, reduced liquidity, limited news and analyst coverage, decreased ability to issue additional securities or obtain financing, and subjection to state-level securities regulation.
• Warrants will expire worthless if the company dissolves and liquidates the Trust Account due to failure to complete a business combination.

Future Outlook

The company intends to continue its efforts to consummate a business combination with Bradbury Capital Holdings Inc. by the proposed extended date of November 20, 2025. An additional extraordinary general meeting will be called at a future date to approve the business combination itself.

Management Comments

• "Our board of directors currently believes that there will not be sufficient time before August 20, 2025 to hold a general meeting at which to conduct a vote for shareholder approval of the Proposed Business Combination."
• "Our board of directors has determined it is in the best interests of the Company and our shareholders to extend the termination date from August 20, 2025 to the Extended Date."
• "Without the Extension, TETE believes that there is a significant risk that TETE will not, despite its best efforts, be able to complete a Business Combination on or before the Termination Date."
• "TETE believes a Business Combination will provide significant benefits to its shareholders."
• "The Board unanimously recommends that you vote or give instruction to vote FOR such proposals."

Industry Context

This filing is characteristic of a Special Purpose Acquisition Company (SPAC) nearing its dissolution deadline and seeking an extension from shareholders. The repeated need for extensions and high redemption rates are common challenges faced by SPACs, particularly in a less favorable market environment for de-SPAC transactions. The delisting from Nasdaq to the OTC Pink Market further highlights the difficulties faced by this particular SPAC in maintaining its public listing and investor interest.

Comparison to Industry Standards

• The repeated need for extensions and high redemption rates are indicative of a challenging SPAC environment, often seen when attractive target companies are scarce or market conditions are unfavorable for de-SPAC transactions. Many SPACs struggle to find suitable targets within their initial timeframe.
• The delisting from Nasdaq to the OTC Pink Market is a significant negative deviation from industry standards for SPACs, which typically aim for a national exchange listing post-combination. This reduces liquidity and investor interest compared to peers listed on major exchanges.
• The redemption price being higher than the market price ($12.71 vs $12.00) is a common feature of SPACs nearing liquidation or extension votes, as it provides a floor for public shareholders, but also incentivizes redemptions, further depleting the trust account.
• The sponsor's continued funding of extensions via non-interest-bearing promissory notes is a standard practice for SPAC sponsors committed to completing a deal, but also highlights the financial burden and risk taken by the sponsor.

Corporate Governance

Related Party Transactions

• The Sponsor has loaned the company an aggregate of $2,817,736 for extension payments as of May 31, 2025, via non-interest-bearing promissory notes convertible into TETE Units or Class A ordinary shares upon business combination consummation.
• In connection with the January 20, 2025, and April 16, 2025, extraordinary meetings, the company entered into Non-Redemption Agreements with the Sponsor and certain institutional investors. Under these agreements, the Sponsor agreed to forfeit shares, and TETE would issue new shares or cash payments to investors if the proposals were approved and the business combination consummated, in exchange for investors not exercising their redemption rights.
• The company's directors and officers have interests in the Extension Amendment Proposal and Trust Agreement Amendment Proposal that differ from other shareholders, primarily due to their ownership of Founder Shares and private placement units, which would become worthless if a business combination is not completed.
• The company will obtain an opinion from an independent investment banking firm or independent accounting firm if a business combination is with a company affiliated with the Sponsor or any of the directors or officers, to ensure fairness to public shareholders.

Stakeholder Impact

• Shareholders (Public): Face a decision to redeem shares at a price potentially higher than the current market price, or to continue holding shares with the risk of further delays or liquidation if the business combination fails. Continued investment carries the potential for future gains if the business combination is successful.
• Shareholders (Sponsor/Initial): Have a significant financial interest in the approval of the extension, as their Founder Shares and private placement units, acquired at a very low cost, would become worthless upon liquidation. They have provided substantial financial support to facilitate extensions.
• Creditors: The company has obligations under the Companies Act to provide for claims of creditors in the event of liquidation.
• Employees: While not directly addressed, a successful business combination would secure the future of the operating entity, impacting potential employment opportunities. Liquidation would result in job losses.

Next Steps

• Hold an Extraordinary General Meeting on August 20, 2025, to vote on the Extension Amendment Proposal, Trust Agreement Amendment Proposal, and Adjournment Proposal.
• If approved, file the amended and restated Articles of Association with the Cayman Islands Registrar of Companies.
• Continue efforts to consummate a business combination with Bradbury Capital Holdings Inc. by the proposed Extended Date of November 20, 2025.
• Call an additional extraordinary general meeting at a future date to approve the Business Combination itself.

Key Dates

Recommendation

The company's history of repeated extensions and significant shareholder redemptions indicates persistent challenges in completing a business combination. The delisting from Nasdaq to the OTC Pink Market further reduces liquidity and investor confidence. Given that the current redemption price of $12.71 is higher than the market trading price of $12.00, public shareholders have an opportunity to exit at a premium to the current market value, mitigating further risk associated with the SPAC's uncertain future and potential liquidation. The high redemption rates in previous votes also suggest a lack of confidence from a significant portion of the shareholder base, reinforcing a cautious stance.

Keywords

SPAC, Technology & Telecommunication Acquisition Corporation, TETE, Bradbury Capital Holdings, Business Combination, Extension, Proxy Statement, SEC Filing, Redemption, Trust Account, Corporate Governance, Shareholder Vote, Nasdaq Delisting, OTC Markets, CFIUS, Liquidation